Harpoon Presents Interim Data from Ongoing Dose Escalation P

Harpoon Presents Interim Data from Ongoing Dose Escalation Portion of T Cell Engager HPN328 Clinical Trial at 2022 ASCO Annual Meeting

Harpoon Presents Interim Data from Ongoing Dose Escalation Portion of T Cell Engager HPN328 Clinical Trial at 2022 ASCO Annual Meeting
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Chicago , Illinois , United States , Boston , Massachusetts , Dana Farber Cancer Institute , American , Robert Uhl , Himisha Beltran , Julie Eastland , Exchange Commission , Harpoon Therapeutics Inc , American Society Of Clinical Oncology , Drug Administration , Nasdaq , Harpoon Therapeutics , American Society , Clinical Oncology , Annual Meeting , Principal Investigator , Lung Cancer , Non Small Cell , Activating Construct , Orphan Drug Designation , Private Securities Litigation Reform Act , Harpoon Therapeutic ,